CompletedPhase 1ACTRN12606000376549

An evaluation of the clinical outcomes of the subvastus versus the medial parapatella approach to total knee replacement

An evaluation of the clinical outcomes (American Knee Society Score, Knee Range of Motion, Quadriceps Function, Functional Mobility, Pain, Patella Vascularity) of the subvastus versus the medial parapatella approach to total knee replacement


Sponsor

Queensland Health

Enrollment

64 participants

Start Date

Jul 14, 2006

Study Type

Interventional

Conditions

Summary

Study Hypothesis: We hypothesise that participants receiving the subvastus approach will enjoy better medium term funtional outcomes than those receiving the medial parapatell approach. Physiotherapists are blinded to the intervention and will collect all outcome measures at each assessment point. Participants are blinded to the intervention.


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This study compares two surgical approaches for total knee replacement: the subvastus approach (which goes under the thigh muscle) versus the standard medial parapatellar approach. It is for adults with osteoarthritis scheduled for their first knee replacement on one knee who can participate in rehabilitation.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Medial Parapatella approach to Total Knee Replacement involves dissection through the quadriceps. The Subvastus approach does not. Assessments will be performed at PreOperative Period, Days 1,2,3; 6

Medial Parapatella approach to Total Knee Replacement involves dissection through the quadriceps. The Subvastus approach does not. Assessments will be performed at PreOperative Period, Days 1,2,3; 6 Weeks, 6 months, 12 months and 18 months post operatively


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12606000376549


Related Trials